throbber
[CANCER RESEARCH 55. 5400—5407. November 15. 1995]
`
`ERBB-2 (HERZ/neu) Gene Copy Number, plSSHER'2 Overexpression, and
`Intratumor Heterogeneity in Human Breast Cancer1
`
`Janos Sziilliisi,2 Margit Baltizs,2 Burt G. Feuerstein, Christopher C. Benz, and Frederic M. Waldman3
`Division of Molecular Cytometry, Department of Laboratory Medicine ll. 3., B. M.. B. G. F.. F. M. W. 1. Brain Tumor Research Institute [8.617.], and Cancer Research Institute
`(C. C. 8.], University of Califomia, San Francisca, California 941430808
`
`ABSTRACT
`
`Amplification of the BEBE-2 (HER-Zlneu) gene is accompanied by
`overexpression of its cell surface receptor product, pissm-Z. Heteroge-
`neity has been observed for both the gene copy number and the level of
`overexpreasion of its protein product. To better understand their relation-
`ship, correlation between the level of cellular expression of p185“‘" and
`ERBB-Z gene amplification was studied in four human breast cancer cell
`lines (ET-474, SK-BR-J, MBA-453, and MCF—7) and in a primary human
`breast tumor sample. The relative expression of p185"“" was measured
`by immunolluorescenee by using now and/or image cytometry while
`correlated DNA analysis was performed on the same cells by fluorescence
`in situ hybridization to determine ERBB-Z gene and chromosome 17 copy
`numbers. Marked heterogeneity was observed in both protein expression
`and ERBB-Z copy number. Despite this heterogeneity, and in accordance
`with previous studies, the average levels of p185’"‘“ expression corre-
`lated well with average ERBB-Z gene copy numbers in the four lines
`examined (r = 0.99). When the relationship between copy number and
`protein expression was studied on a ceil-by-cell basis, pissm“ expres-
`sion correlated with both the absolute number of ERBB-Z gene copies/cell
`(r = 0.59—0.63) and chromosome 1? copy number (r = 0.45—0.61).ltls of
`interest that there was weak or no correlation between piss’w“ protein
`expression and the ERBB—Z copy number:chromosome 1‘] copy number
`ratio (r = 0.0—0.25). In more than one-half of cells expressing a high level
`of p185"”", the chromosome 17 copy number was high (two or three
`times the average copy number), whereas <2% of an unselected popula-
`tion had a high chromosome 17 copy number. Bmmodeoxyuridine incor-
`poration indicated that the Svphase-labeling index was homogeneous
`across various pissm"~expressing subpopulafions in the SK-BR-3 cell
`line. Analysis of the primary breast tumor sample showed results similar
`to the cell lines, supporting the strong possibility of a mechanistic link
`among p185"E“” overexpression, ERBB-Z amplification, and high chro-
`mosome l7 copy number.
`
`INTRODUCTION
`
`A characteristic feature of cancer cells is the unregulated expression
`of genes involved in cellular growth control. One of these genes is the
`ERBB-Z (HER-Z/neu) prom-oncogene, which encodes a M, 185,000
`transmembrane glycoprotein (plBSHER‘z) that belongs to a subfamily
`of growth factor receptors having intrinsic tyrosine kinase activity,
`including the epidermal growth factor receptor and the receptors
`HER-3 and HER-4 (1—3).
`Amplification and overexprcssion of ERBB-Z is found in 25-30%
`of primary human breast cancers and is associated with a poor clinical
`outcome (4-45). This suggests that overexpression of p185""”“2 plays
`a role in the pathogenesis of some human breast cancers (5, 6).
`Although overcxprcssion of plSS’mu‘2 is usually accompanied by
`
`Received 6/8/95; aweptcd 9/14/95.
`The costs of publication of this article were defrayed in part by the payment of page
`charges. This article must therefore be hereby marked advenismienr in accordance with
`18 U.S.C. Section l734 solely to indicate this fact.
`‘ This march was supported by NIH Grants Cit—49056 and (IA-44768 and by United
`States-Hungarian Joint Fund for Science and Technology (IF292/928).
`2 Present address: Department of Biophysics, Medical University School of Debrecen.
`Nagyerdei krt. 98. H-4012 Debrecen, Hungary.
`' To whom requests for reprints should be addressed. at Department of Laboratory
`Medicine. MGR-230. Box 0808. University of California at San Francisco, San Francisco,
`CA 94143-0808. Phone: (415) 476-3821; Fax: (415) 476*8218; E—mail: waldman@
`dmc.ucsf.edu.
`
`tumors overexpress
`amplified ERBB-2 in tumor DNA, rare breast
`p185"“3’"2 protein or c-ERBB-Z mRNA levels in the absence of
`detectable gene amplification (7).
`Although amplification of ERBB-Z is generally considered to be a
`significant prognostic indicator in patients with breast cancer,
`its
`applicability continues to be controversial, in part because of analyt-
`ical discrepancies associated with the methods traditionally used to
`evaluate its amplification and/or overexpression. These techniques
`include Southern blotting, slot blot analysis, and FISH“ for detection
`of amplification, while ELISA, Western blotting, immunohistochem-
`istry, and immunofluorescence are used to evaluate overexpression
`(8—15). Because FISH allows the observer to distinguish small sub~
`populations of amplified cells,
`it
`is more sensitive than blotting
`techniques. In addition, FISH allows one to identify particular loca-
`tions where aberrations exist in single tumor specimens (10, 14).
`Similarly, because immunohistochemically stained slides are difficult
`to quantify and because ELISA and Western blotting data do not
`provide information concerning heterogeneity, immunofluoresccnce
`has advantages over these other methods (13, 14).
`Marked heterogeneity has been described in primary breast cancers
`in both the copy number of ERBB—Z/cell and in the level of p185"”‘2
`protein (5—12). Although cell-to-cell differences may be due in part to
`analytical variation, genetic and epigenetic dispersion may also play
`significant roles. This heterogeneity provides a potential source for the
`selection of subclones with increased malignant and metastatic poten-
`tial, especially in the context of therapeutic targeting based on
`ERBB~2 expression.
`Although amplification of ERBB-Z correlates well with overexpres-
`sion of p185"‘”“2 protein in cell populations (5, 6, 9, 11, 14—16). the
`correlation has not been made on a cell-by—cell basis. The present
`communication describes our analysis of the extent to which BREE-2
`gene amplification relates to the expression of p185HEM on a single
`cell basis. We have found that although pillsmi‘”2 expression corre~
`lates with the ERBB—Z copy number/cell, pISSHER‘2 expression cor-
`relates poorly with the ERBB-Z copieszchromosome 17 copies ratio.
`Surprisingly, there was correlation between pISSHER" expression and
`chromosome 17 copy number, suggesting that hyperploidy may be
`related to the p185'm“2 expression.
`
`MATERIALS AND METHODS
`
`Cell Lines. Human breast cancer cell lines, 811474, SK~BR—3, MBA-453,
`and MCF-7 were obtained from the American Type Culture Collection (Roclo
`ville, MD) and grown according to their specifications. The four cell lines were
`characterized previously for ERBB-Z gene amplification (10). For flow cyto~
`metric immunofluorescence measurements. cells were harvested either by
`trypsin or 25 mM EDTA in PBS (pH 7.2; Ref. 17). For slide-based immuno-
`fluorcsccnce measurements, cells were cultured in slide chambers (Nunc, inc,
`Naperville, 11.). For BrdUrd (Sigma Chemical Co., St. Louis, MO), labeling
`cells were pulsed with 100 MM BrdUrd for 60 min. Cells were washed three
`times with PBS containing 1 mM CaCl2 before immunofluorescence labeling.
`Tumor. A biopsy from a node positive, T2 tumor, was frozen immediately
`after resection. imprint preparations were made after thawing by gently touch‘
`
`Hospira v. Genentech
`|PR2017-00737
`annlnaded fmm cannerres annrimlrnals mm on November 14 7017 ((3 1995 American Association fnr Cancer
`
`1
`
`‘ The abbreviations used are: HSH, fluorescence in sim hybridization; BrdUrd, bro—
`modeoxyuridine; chr, chromosome; Fl. fluorescence index. G enent8Ch 2064
`5400
`
`Genentech 2064
`Hospira v. Genentech
`IPR2017-00737
`
`1
`
`

`

`ERBB-2 EXPRESSION AND AMPLIFICATION
`
`ing the slide surface with tumor material. Slides were then fixed in 1%
`formaldehyde for 60 min at room temperature and subsequently fixed and
`stored in 70% ethanol. The autofluorescence of air-dried touch imprint prep-
`arations was too high for reliable immunofluorescence analysis. Fresh fixation
`of slides in 1% formaldehyde and subsequently in 70% ethanol reduced
`autofluorescence significantly.
`Immunolabeling. For flow cytometry, unfixed trypsinized cells were in-
`cubated with 5 ug/ml mAbl (Triton, Alameda, CA) raised against the extra-
`cellular domain of pI8SHER‘z, in the presence of 1% BSA on ice for 45 min,
`washed three times with PBS, and incubated with fluoresceinated rabbit
`antimouse lgG (1:100 dilution; Sigma) at 0°C for 45 min. After washing with
`PBS, cells were fixed in 1% formaldehyde solution and stored for not more
`than 3 weeks at 4°C before analysis.
`For image analysis. cells were first fixed in 0.5% formaldehyde solution for
`20 min at room temperature and in 70% ethanol at 4°C overnight. Cells on
`slides could be stored in ethanol at 4°C for not more than 2 months. Slides were
`
`then preblocked in 5% Carnation dry milk, 0.1% Triton X-100 in 4X SSC (1X
`SSC is 0.15 M NaCl and 0.015 M sodium citrate) for 10 min at room
`temperature. Staining was at room temperature for 45 min. Samples were first
`incubated with C8“ antibody (BioGenex, San Ramon, CA) specific to the
`intracellular domain of the pliiS'mR'2 protein, diluted (1:200) in the blocking
`buffer, washed twice with the blocking buffer, and incubated with fluorescein—
`ated rabbit antimouse lgG (1:100; Sigma). After washing, samples were
`refixed in 1% formaldehyde solution in PBS and kept at 4°C for not more than
`3 weeks before microscopic analysis. During this time, no significant deteri-
`oration of the fluorescence signal was observed.
`To control for nonspecific staining, cells were preincubated with irrelevant
`monoclonal antibody of the same isotype before staining with fluorescein-
`conjugated rabbit antimouse lgG. We also compared immunofluorescence
`labeling of MBA-453 and SK-BR-3 cells harvested with either trypsin or 25
`mM EDTA in PBS. Trypsinization caused a 10~15% loss in fluorescence
`intensity as compared to cells harvested with 25 mM EDTA (data not shown).
`Because this loss was not significant, and the two other cell lines could not be
`harvested with 25 mM EDTA, we used trypsin to harvest cells for flow
`cytometric analysis. Results from monoclonal antibody (mAbl) raised against
`the extracellular domain of p185"'“”“2 protein were similar to those from
`monoclonal antibody (CBli) raised against the intracellular domain of the
`protein. With mAbl. prefixation was unnecessary, resulting in lower non-
`specific binding.
`Fiow Cytometry. Cell suspensions were filtered through a 35—um nylon
`mesh to remove aggregates before flow cytometric analysis. Analysis was
`performed on a FACScan flow cytometer (Becton Dickinson, San Jose. CA)
`equipped with a 15 mW argon laser (488 nm) and pulse-width doublet
`discrimination. A total of 10,000 events were recorded in list mode after
`logarithmic amplification of the fluorescence signal.
`Digital Image Analysis. The fluorescence of cells stained on slides was
`analyzed by using a digital image analysis system based on a Zeiss Axioplan
`microscope equipped with the Microlmager 1400 Digital camera (Xillix Tech‘
`nologies Corp, Vancouver. British Columbia, Canada). images were captured
`through a fluorescein excitation filter. beam splitter, and emission filter by
`using a X20, NA: 0.5 Plan Neofluar objective. images were processed and
`quantitatively analyzed with a Sun iPX workstation using Soil-Image software
`(National Research institute, Delft, The Netherlands). Local background flu—
`orescence was determined for each image, and the average autofluorescence of
`the isotypic control cells was subtracted from the total fluorescence intensity of
`labeled cells. The Fl was defined as a ratio of the corrected total fluorescence
`intensity of labeled cells to the mean autofluorescence of the isotypic control
`cells.
`
`images acquired; they were then hybridized for gene copy number and scored
`after relocating cells analyzed previously. After immunofluorescence analysis,
`slides were refixed in methanclzacetic acid (3:1; Carnoys solution) and air
`dried. FISH was performed as described previously (19) with modifications.
`Briefly, cells on slides were denatured in 70% forrnamide~2X SSC at 73°C for
`3.0 min, dehydrated in graded ethanols, treated with 0.25 rig/ml proteinase K
`(Sigma) in 20 mM TRIS buffer (pH 7.5) containing 2 mM CaCl; for 7.5 min at
`37°C, and again dehydrated. The hybridization mixture was denatured at 73°C
`for 5 min, reannealed for 30 min at 37°C, and applied to warmed slides. Ten
`at of hybridization mixture contained 6 ng of fluoresceinated chromosome 17
`centromeric probe, 34 ng of rhodaminated ERBB‘Z probe, and 10 ng of
`unlabeled, sonicated human placean DNA (Sigma) in 50% formamide, 2X
`SSC, and 10% dextran sulfate. Hybridization was overnight at 37°C. Slides
`were washed three times for 10 min each in 55% formarnide-ZX SSC, once in
`2X SSC at 45°C, and once in 2X SSC at room temperature. Nuclei were
`counterstained by using 4',6-diamidino~2~phenylindole hydrochloride (Molec-
`ular Probes, Eugene, OR) at 0.01 rig/ml in antifade solution (20).
`Simultaneous detection of BrdUrd incorporation and dual FISH staining
`was performed with three fluorescent dyes (fluorescein- and rhodamine-la~
`beled probes and a Cascade Blue-conjugated antibody; Ref. 21). Cells and
`probes were denatured and hybridized as described above. After washing,
`slides were prebloclted in 5% Carnation dry milk and 0.1% Triton X-100 in 4X
`SSC for 10 min at room temperature. Ali staining reactions were at room
`temperature for 30 min. Slides were incubated with 1U4 mouse anti-BrdUrd
`(1:400; Caltag, La Jolla, CA), diluted in blocking buffer, washed twice with
`blocking buffer, and incubated with Cascade Bluecantimouse lgG (1:300;
`Molecular Probes), and coverslipped with antifade solution alone.
`Scoring of Interphase Nuclei. Cells analyzed previously for cell surface
`expression of p185mm'2 protein were relocated on the basis of their coordi~
`nates and scored for chromosome 17 and ERBB-Z signals by using a X100
`NA:1.3 Plan Neofluar oil
`immersion objective and a computer-controlled
`stage. ERBB-Z doublets were counted as separate signals. Broken,
`torn,
`squashed, smeared, or overlapping nuclei were ignored. Each hybridization
`was accompanied by a control hybridization using normal lymphocytes. The
`scoring results were expressed both as an absolute ERBB~2 copy number/cell
`and as the ERBB-Z copy number relative to the 17 centromere copy number.
`Three color images were acquired by using the digital imaging analysis
`system described previously. A triple~band-pass beam splitter and emission
`filters were used (22). Excitation of each fluorochmme was accomplished by
`using singloband-pass excitation filters in a computer-controlled filter wheel.
`This made it possible to collect sequential, properly registered images of the
`three fluorochromes (4’,6~diamidino—2-phenylindole hydrochloride or Cascade
`Blue, fluorescein, and rhodamine). The three-color images were processed
`with a Sun IPX workstation using Scil-lmage software for pseudocolor display.
`Statistical Analysis. Significance levels for differences in gene copy num-
`ber between the p18SHER‘2 bright and total cell populations were determined
`by contingency table analysis.
`
`RESULTS
`
`ERBB-Z Amplification and Expression In Breast Cancer Cell
`Lines. Four breast cancer cell lines, MCF-7, MBA-453, SK-BRJ,
`and BT474, known to have various levels of amplification of the
`ERBB~2 gene (10) were studied for distribution of ERBB—Z gene copy
`number and chromosome 17 centromere copy number (Fig. 1). Am-
`plification of the ERBB-Z gene can be expressed as copy number/cell
`or as copy number relative to chromosome 17 copy number. Using a
`DNA Probes and Probe Labeling. Two contiguous ERBB-Z cosmid
`relative measure is especially important for those cell lines that are
`clones (cRCNeui and cRCNeu4), together spanning 55 kb of genomic DNA
`aneusomic for chromosome 17. Amplification of ERBB-Z gene was
`(10), were used in combination with a probe specific for the chromosome 17
`observed in MBA-453, SK-BR-3, and 811474 cell lines, using either
`pericentromeric sequence (pl7H8; Ref. 18)
`for two~color FISH analysis.
`the definition of amplification as total ERBB-Z copies/cell or the ratio
`Probes were directly labeled with fluoresceinal I‘dUTP or tetramethylrhodam-
`of ERBB-Z copy number to chromosome 17 copy number. There was
`ine-i l-dUTP (Boehringer Mannheim, lndianapolis, IN) by nick translation by
`marked heterogeneity for ERBB-2 copy number, chromosome 17 copy
`using commercially available kits (Bethesda Rmh Laboratories, Gaithers-
`burg, MD).
`number, and their ratios in the three cell lines with ERBB-Z amplifi‘
`Fluorescence in Sim Hybridization and Staining for BrdUrd. Dual
`cation. in MCF—7, the ERBB-Z gene was deleted (ERBB—Z gene copy
`analysis of gene copy number and protein expression was done as a two-stage
`number was less than the chromosome 17 copy number/cell) and there
`procedure. Slides were first stained for protein expression and fluorescence
`was less heterogeneity in ERBB—2 gene copy number/cell and in the
`5401
`
`2
`
`Downinaded fmm mannerms nanrimrrnals nm on November ’14 7017 «D 1995 American Association for Cancer
`
`2
`
`

`

`ERBB-Z EXPRESSION AND AMPUFICATION
`
`50
`
`K
`335
`3:
`
`QT.
`as;a.
`:3:
`
`“40Q
`
`E:
`
`30
`
`Z 50
`
`2°
`
`10
`
`Fluorescence Intensity
`
`ERBB-thromosome 17 ratio. The mean values and the SDs of the
`
`copy number distributions are summarized in Table 1.
`We next characterized the expression levels of the ERBB-Z gene
`product p18SHE‘z'2 by flow cytometry. Fig. 2 shows the fluorescence
`intensity histograms of the four cell lines labeled with mAbl against
`p18SHER'2. Heterogeneity of expression of p185"ER'2 was similar in
`the four cell lines. The MCF-7 cell line was the least positive, only
`twice background, whereas the BT-474 cells were the most positive.
`
`100
`so
`
`so
`
`
`
`A
`
`I tar-474
`I MBA-453
`El SK-BR-3
`MCF-7
`
`
`
`
`
`
`NflNNnnVVVIWWWhh”
`“NWGWQWQWGMQWOWQWQ
`
`ERBB-ZSignaIs/Cell
`
`B
`
`Fig. 2. Frequency distribution of fluorescence intensity after immunofluorescence
`staining for p185"'5“. Try inized cells were labeled with mAbl raised against the
`extracellular domain of p185
`“‘2 and then with fluorescein-conjugatcd rabbit antimouse
`130. An irrelevant primary antibody of the same isotype. followed by fluorescein-
`conjugated rabbit antimouse lgG. was used for the blank control (SK-BR-S cells). The
`mean values of these distribution curves are summarized in Table 1. Note that the level
`of heterogeneity (width of the intensity profiles on this lo intensity scale) is similar in the
`{our cell lines, although the absolute amount of p185"“' varies greatly from line to line.
`
`.9
`73
`0
`
`5
`[-1
`
`be
`
`[W
`
`80
`
`so
`
`40
`
`20
`
`0
`
`8°
`
`so
`
`40
`
`20
`
`o
`
`0123456789101112
`
`Chr17Signals/Cell
`
`C
`
`00.51234 5678910111213
`
`ERBB-Z Signals/CM 17 Signals
`
`The mean values and the 80s of the fluorescence intensity histograms
`are summarized in Table 1. The mean fluorescence intensity was
`strongly correlated with the mean ERBB‘Z copy number/cell
`(r = 0.99; Table 1). A strong correlation was also observed between
`the mean protein expression and mean ERBB-chhromosome 17 ratio
`(r = 0.99), whereas there was a weaker correlation with average
`chromosome 17 copy number (r = 0.75).
`ERBB-Z Gene Expression and Amplification on a Single Cell
`Basis. Protein expression and copy number were measured in the
`same individual cells to study their correlation on a single cell basis.
`This was especially relevant given the wide range in both copy
`number and immunofluorescence observed (Figs. 1 and 2). Immuno‘
`fluorescence intensity of individual SK—BR-3 and MBA-453 cells was
`studied by image microscopy, and the same cells were identified and
`scored for ERBB-Z gene and chromosome 17 copy number after dual
`FISH labeling. The fluorescence intensity was too low in MCF-7 to
`perform quantitative image cytometry, and BT474 cells could not be
`separated from each other during image analysis because of their
`piled-up growth pattern.
`Correlated measurement of p185"8“‘2 expression and ERBB-Z
`copy number was performed in the same cells by consecutive analysis
`(Fig. 3). The fluorescence images of cells displayed in Fig. 3B are
`shown after double—target hybridization in Fig. 3C. The green signals
`correspond to chromosome 17 centromere, and the red signals to
`ERBB-Z signals. The heterogeneity of p185mm'2 expression in SK—
`BR-3 cells by image microscopy (Fig. 3A) was similar to that found
`by flow cytometry (Fig. 2).
`The linked analysis of pISSH'ER'2 expression and ERBB-Z gene
`amplification in SK-BR—3 cells is shown in Figs. 4 and 5. Note the use
`of a Fl for these measurements, rather than absolute intensity (as was
`used for the flow measurements), in order to control for the increased
`levels of autofluorescence in these fixed samples. ERBB-Z copy
`number showed a significant correlation with protein expression on a
`cell-by-cell basis. The correlation was stronger using absolute
`ERBB-Z copy number/cell (Fig. 4A) than when using a relative
`5402
`
`Fig. l. Number of ERBD-Z and chromosome 17 centromere copies in four breast cancer
`cell lines. A, frequency distribution of ERBB'Z signals/cell; B. chromosome l7 signals/
`cell; C, ERBB~21chromosome (Chr) 17 ratio. The values along the abscissa represent the
`lower limits of the range of values for each category. At least 100 cells were scored to
`create the distribution histograms. The mean values and their SDs are summarized in
`Table 1. Note the wide heterogeneity present in all but the MCF—7 distributions.
`
`Table l ERBB-Z amplification and expression in breast cancer cell lines
`Breast cancer
` cell lines ERBB—Z" Chr 17" ERBB-Z/Chr 17 F1"
`
`
`
`
`MCFu7
`2.2 2 0.5"
`3.8 e 1.0
`0.6 x 0.2
`20 2 9
`
`MDA—4S3
`
`SK-BR-3
`
`11.0239
`
`4.1 s 1.6
`
`31.0 x 9.0
`
`6.9 2 1.0
`
`2.8: 1.0
`
`4.5 a 1.2
`
`186: 75
`
`326 z 114
`
`2mm 549 2 165 52.0 s 11.3 6.0 .2 1.1 9.0 .+. 2.3
`
`
`" ERBB-Z copy number/cell.
`b Chr. chromosome 17 copy number/cell.
`‘ Mean fluorescence intensity determined from flow cytometric histograms.
`4 Data expressed as mean. :SD.
`
`
`
`
`
`3
`
`Downinaded fmm cannerres aanrimrmnls nm on Nm/emher 14 7017 «:7 1995 American Assnniatinn for Cancer
`
`3
`
`

`

`ERBB-Z EXPRESSION AND AMPUFICATION
`
`
`
`measure of ERBB-Z amplification (ERBBv22chromosome 17 copy
`to phenotypic dispersion, the genetic composition of “bright” cells (with
`more than four times more fluorescence intensity than the nonspecific
`number ratio; Fig. 48). There was also a correlation seen between
`staining of isotypic control cells) was analyzed as a separate group. We
`pISSHER‘Z expression and copy number of chromosome 17 (Fig. 4C),
`compared the distribution of ERBB-Z copy number (Fig. 5A), ERBB—Z:
`perhaps due to an second association between aneuploidy and ERBB~2
`chromosome 17 mpy number ratio (Fig. SB) and the chromosome 17
`amplification.
`copy number (Fig. 5C) of bright cells to an unselected population and
`A subpopulation of cells was seen, which stained especially brightly
`found that these differences were all highly significant.
`for pl85"5“'2. To test whether this was due to genetic heterogeneity or
`5403
`
`Fig. 3. Linked detection of pl85m‘m‘z expression and gene amplification in individual cells. A. SK-BR~3 cells display immunofluoresoence staining for leSHBR" expression (XZO
`objcaive) after staining with Mb]. 8. computer magnification (X5) of the rectangle in A. C, FISH detection of ERBB-Z (red) and chromosome 17 centrorneres (green) in identical
`cells shown in B (x100 objective). Cells were refixed after immunofluorescence labeling and denatured and hybridized with directly labeled £RBIL2 and chromosome 17
`centromere~spccific probes. Not all signals are visible in this image because the plane of focus is thinner than the specimen. Anti-BrdUrd labeling (blue) is positive in the top cells.
`These are pseudocolor, contrast-enhanced digital images.
`
`4
`
`annlnaded from nannerms aanrimtmals nm on Nnvemher 14 7017 © 1995 American Associatinn fnr Cancer
`
`4
`
`

`

`ERBB-Z EXPRESSION AND AMPUFICATlON
`
`significant difference (P = 0.29) in the average fluorescence intensity.
`S-phase cells had a higher average ERBB-Z gene copy number and
`ERBB-2:chromosome 17 copy number ratio than did non-S~phase
`cells (43.7 versus 38.7 and 6.3 versus 5.0, respectively), perhaps
`because doublets forming during DNA synthesis were scored as two
`separate gene copy numbers as described in “Materials and Methods."
`The labeling index of the whole cell population (39.7% of 224 cells)
`and for cells with >10 chromosome 17 copies (38.3% of 60 cells) did
`not differ.
`
`ERBB-2 Gene Expression and Amplification on a Primary
`Tumor Sample. The results of consecutive analysis of plBSHER'2
`expression and ERBB—Z gene amplification in primary tumor cells
`(case no. 8372) are shown in Figs. 8 and 9. Positive correlations were
`found between p185HEM expression and ERBB-2 gene copy number
`(Fig. 8A), the ERBB-chhromosome 17 ratio (Fig. 88), and the chro-
`mosome 17 copy number (Fig. 8C). There were significant differ-
`ences in the distribution of the ERBB-Z copy number (Fig. 9A ), the
`ratio of ERBB-2:chromosome copy number (Fig. 9B), and the chro-
`mosome l7 copy number (Fig. 9C) when bright cells were compared
`to the unselected population.
`In general,
`the correlation patterns
`observed in this touch imprint preparation were similar to those
`observed in tumor cell lines.
`
`SK-BR-3
`
`20
`
`I Average
`Bright (FM)
`
`
`
`
`
`
`,
`.
`I
`5’
`fl
`.p 15
`5 5“ H
`5 5555‘5'
`4 151.1414
`cam—tnunnev'mmw'eibh'oémogg
`ERBB-Z Signals/Chr 17 Signals
`
`p<0.002
`
`100
`
`A
`
`a:
`
`0
`
`20
`
`40
`
`too
`80
`60
`ERBB-Z Signals/Cell
`
`120
`
`140
`
`o ‘
`
`N
`
`.g
`.5
`8E
`
`i 8E
`
`0
`
`2
`
`4
`
`6
`
`8
`
`10
`
`l2.
`
`l4
`
`ERBB-Z SignaldChr 17 Signals
`
`
`
`Chr 17 Signals/Cell
`
`Fig. 4. ERBB-Z gene expression and amplification in single SK—BR-3 cells. Expression
`level of plSSmiR'2 protein (Fl) plotted against: A. ERBB-Z copy number; 8. ERBB-Z:
`chromosome l7 ratio; and C. chromosome 17 copy number. Cells were labeled with
`antibody (CBl 1) against the intracellular domain of praSHE“ protein. Data from 184
`cells are shown. There is a good correlation between pltism’J"2 expression and copy
`number of either ERBB-2 or chromosome 17 centromere (A and C). The correlation
`between plssmk‘2 expression and ERBB-2:chromosome l7 copy number ratio was
`weaker (B).
`
`The results in MBA-453 cells were similar to SK-BR—3 cells for
`
`i3
`U 20
`g
`E"
`o
`e
`
`10
`
`0
`
`80
`60
`
`40
`
`20
`
`ERBB~2 gene amplification and protein expression (Figs. 6 and 7).
`However, there was no correlation between protein expression and
`ERBB-chhromosome 17 copy number ratio (Fig. 6B), and the distri-
`bution of ERBB-Ztchromosome l7 ratio of bright cells did not differ
`significantly from the unselected population (Fig. 7B). In both cell
`lines, the centromere 17 copy number was high (two or three times the
`average copy number) in >50% of the bright cells (expressing a high
`level of pISSHER'z), whereas <2% of the unselected population had a
`high chromosome 17 copy number.
`Relationship between DNA Synthesis and ERBB-Z Gene Ex-
`pression and Amplification. We next addressed the issue of
`whether the bright cells having high p18SHER'2 expression and high
`chromosome 17 copy number were proliferatively active. SKBR-3
`cells were pulse labeled with BrdUrd, pISSHER‘2 expression was
`determined before fixation, and then BrdUrd incorporation and dual-
`color FISH were detected simultaneously (for demonstration see Fig.
`Fig. 5. ERBB‘Z copy number (A). ERBBv21chromosome (Chr) 17 ratio (B), and
`3C) Correlation between ERBB-Z gene amplification and protein
`chromosome 17 copy number (C) in unselected and in highly plSS"””-expressing
`expression in these cells (data not shown) was similar to that found in
`(Fl > 4) SK—BR-3 cells. Distributions of bright cells were determined from cells plotted
`prefixed cells (Figs. 4 and 5). When BrdUrd-positive cells (cells in S
`in Fig. 4. Cells that expressed pll'ZSHEM at a high level had significantly more copies of
`ERBB‘Z and chromosome 17, and a higher ratio of the two. than an unselected population,
`phase) were compared with BrdUrd~negative cells,
`there was no
`5404
`
`C
`
`(0.000]
`
`P
`
`0 c—umvmwhwaO—vamwrw
`v-uv-tr-iv-iv-r—i—r—r—i
`
`Chr 17 Signals/Cell
`
`5
`
`Downloaded from oanoorros noorionrnalg oro on November 14 9n17 (<3 1995 Amorioan Association for Connor
`
`5
`
`

`

`ERBB-2 EXPRESSION AND AMPUFICATION
`
`linkage between gene copy number and protein expression was still
`present within each cell line (r = 0.59—0.72) but was weaker than that
`observed when cell
`lines were compared at
`the population level
`(r = 0.99).
`Several reasons may account for the observed dissociation between
`ERBB-Z copy number and protein expression. A normal dispersion in
`ERBB-Z transcription and translation rates, or in the half-lives of RNA
`transcripts and protein products, might lead to a weakened linkage
`between genotype and phenotype. ERBB-2 transcript levels in ampli—
`fied SK-BR-3 and BT-474 cells are 20—46 times that of immortalized
`
`but nonmmorigenic BBL-100 breast epithelial cells, although the
`average level of ERBB—Z gene copy number in the amplified cell lines
`was only 8-fold that of the HBL-IOO cells (determined by Southern
`blotting) (26). Another cause of the lower association on a cell-by-cell
`basis is analytical variation, for either gene copy number or immu-
`nofluorescence intensity, which is much less of a factor when the
`entire population is measured. Asymmetric distribution of p185flm‘2
`protein occurring during mitosis, which occurs in exponentially grow-
`ing cell populations (27), might also lead to less linkage between gene
`copy number and expression.
`lt is of interest that p185""3"“2 expression and the ERBB‘Z copy
`number:chromosome 17 copy number ratio were not closely linked
`
`MBA-453
`
`.3fl3h((FI>4)
`
`20
`
`ll)
`
`0
`
`3‘15
`.
`5
`M
`I
`I;
`5
`V59
`I
`,1
`4547.0!
`NVGQQ—rVOQQNQ‘OflQNVO”:
`“mu—HNNNNNMMMMMV
`
` I Average
` '5
`%TotalCells
`
`A '
`
`o
`
`to
`
`20
`
`so
`
`40
`
`so
`
`I00
`
`ERBB-z Signals/Cell
`
`
`
`fluorescenceIndex
`
`' o
`
`l
`
`2
`
`3
`
`4
`
`s
`
`6
`
`1 '
`
`o
`
`10
`Chr 17 Signal/Cell
`
`20
`
`Fig. 6. ERBB—Z gene expression and amplification in individual MBA—453 cells. Fl
`plotted against: A. ERBB-Z copy number; 8. ERBB~21chromosome l7 ratio; and C.
`chromosome l7 copy number. Cells were labeled with antibody (CBll) against the
`intracellular domain of plSS'mn'2 protein. Data from 239 cells are shown, There is a good
`correlation between plifim‘u‘2 expression and copy number of either ERBB-Z or chro—
`mosome l7 centromere (A and C) but no correlation between pl85m‘2 expression and
`ERBB-Z to chromosome (Chi) l7 ratio (8).
`
`DISCUSSION
`
`Overexpression of plBSmER'2 can occur as a result of either DNA
`amplification or by increased levels of RNA transcription. Concordant
`ERBB-Z gene amplification and p185"”‘2 overcxpression has been
`found in both human mammary cancers and cell lines, with good
`correlation between the level of ERBB-2 gene amplification and the
`average plSSHER'2 protein overexprcssion (5, 6, 9, 11, 14—16, 23—25).
`However, there has been no prior analysis of this genotype—phenotype
`association on a single-cell basis.
`To investigate the cell-bycell basis for the correlation between
`ERBB-Z amplification and overexpression, several well-established
`breast cancer cell lines having a wide range of gene amplification and
`protein expression were studied, as was a primary breast
`tumor
`sample. The levels of gene amplification in the cell lines, as detected
`by FISH, were equivalent to those reported previously by Southern
`and slot blot analysis (10). We found that the population mean values
`for p18SHER'2 protein expression were concordant with their average
`Fig. 7. BREE-2 copy number (A ), ERBB‘thromosome l7 ratio (B). and chromomme
`(Chr) 17 copy number (C) in unselected and in bright (Fl > 4) MDA-453 cells.
`ERBB-Z gene copy number. However, on a cell-by-cell basis, signif-
`Distribution of bright cells was determined from cells plotted in Fig. 6. Cells that express
`icant heterogeneity was present both in gene copy number (detected
`p185HEM at a high level have more copies of both ERBB—Z and chromosome 17 than does
`by FISH) and in protein expression level (by immunofluorescence
`an unselected population. There was no significant difference between unselected and
`bright cells in the distribution of ERBB-chhromosome 1? ratio.
`using two different p185"E“'2-specific monoclonal antibodies). The
`5405
`
`8"
`
`60
`
`40
`
`20
`
`c
`
`<0.00001
`
`P
`
`0 a—unvmwrmae—uumvmoh»
`~~~—~~~~~
`
`Chr 17 Signals/Cell
`
`6
`
`Downloaded from nannerms nanrimirnnls om rm Nnvemher 14 7017 (C) 19.05 American Assnniatinn for Cancer
`
`6
`
`

`

`ERBB-Z EXPRESSION AND AMPUFICATION

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket